Risk‐based versus universal PrEP delivery during pregnancy: a cluster randomized trial in Western Kenya from 2018 to 2019
Pregnant women seeking routine MCH care were randomized into Universal (all received PrEP counseling and self-selected whether to initiate PrEP) or Targeted (HIV risk assessment to determine PrEP offer). There was no difference in maternal HIV incidence or frequency of appropriate PrEP use between arms. The researchers concluded that universal PrEP is best for integrating into MCH systems.
Resource Details
- Study Type
- Randomized clinical trial (RCT)
- Year
- 2023
- Population
- HIV-uninfected women, Pregnant Women
- Author
- Kinuthia J, Dettinger JC, Stern J, Ngumbau N, Ochieng B, Gómez L, Abuna F, Watoyi S, Marwa M, Odinga D, Wagner AD, Richardson BA, Pintye J, Baeten JM, John-Stewart G.
More Publications & Resources
Providing PrEP to Pregnant and Breastfeeding Women
Clinical Practice Guidelines for Providing PrEP for Pregnant and Breastfeeding Populations
Guidelines on Lenacapavir for HIV Prevention and Testing Strategies for Long-Acting Injectable Pre-Exposure Prophylaxis
PrEP and PEP Guidelines-Zambia
PrEP Lenacapavir Implementation Guidelines
Provider Training Toolkit on Use of Oral and Long-acting HIV PrEP: Lenacapavir-Focused Learning Pathway (Lessons 1-4)
Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP
Inclusion of Pregnant and Lactating People in the PURPOSE 1 Study: Efficacy, Safety, and Pharmacokinetics
Lenacapavir Provider Tools and Job Aids
PrEP Drug Interactions
Zambia PrEP Training Materials for Clinicians and Community Mobilisers
No results found.